20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Corcept Therapeutics Incorporated (CORT) operates in the BIOTECHNOLOGY industry and is headquartered in Redwood City, United States with about 730 employees. Its market capitalization is roughly $12 billion. In the fiscal year ended 2025-12-31, CORT reported $761M in revenue and $100M in net income.
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
Interactive charts & full statements → Open the CORT valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $831M | $761M | $675M | $482M | $402M | $366M | $354M | $306M | $251M | $159M | $81M | $50M | $27M | $10M | $3M | $0M | — | $0M | $0M | $0M | $0M |
| Gross Profit | $817M | $748M | $664M | $476M | $396M | $361M | $348M | $301M | $246M | $156M | $79M | $49M | $26M | $10M | $3M | $0M | — | $0M | $0M | $0M | $0M |
| Gross Margin % | 98.3% | 98.3% | 98.4% | 98.7% | 98.7% | 98.6% | 98.4% | 98.2% | 97.9% | 97.8% | 97.5% | 97.3% | 96.7% | 98.6% | 97.2% | — | — | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income (EBIT) | $6M | $45M | $137M | $107M | $113M | $124M | $128M | $112M | $89M | $53M | $10M | ($3M) | ($28M) | ($41M) | ($36M) | ($32M) | ($27M) | ($20M) | ($20M) | ($12M) | ($26M) |
| Operating Margin % | 0.8% | 5.9% | 20.3% | 22.2% | 28.0% | 34.0% | 36.2% | 36.4% | 35.6% | 33.2% | 12.5% | -6.9% | -104.0% | -400.7% | -1096.8% | — | — | -69827.6% | -9420.6% | -2540.5% | -8701.4% |
| Net Income | $55M | $100M | $140M | $106M | $101M | $113M | $106M | $94M | $75M | $129M | $8M | ($6M) | ($31M) | ($46M) | ($38M) | ($32M) | ($26M) | ($20M) | ($20M) | ($12M) | ($25M) |
| Net Margin % | 6.6% | 13.1% | 20.7% | 22.0% | 25.2% | 30.7% | 30.0% | 30.7% | 30.0% | 81.1% | 10.0% | -12.7% | -118.2% | -444.2% | -1150.5% | — | — | -69537.9% | -9598.6% | -2401.0% | -8460.2% |
| EBITDA | $23M | $68M | $163M | $126M | $116M | $128M | $130M | $114M | $90M | $53M | $10M | ($3M) | ($27M) | ($41M) | ($36M) | ($32M) | ($26M) | ($20M) | ($20M) | ($12M) | ($26M) |
| Earnings Per Share (EPS) | $0.42 | $0.83 | $1.23 | $0.95 | $0.87 | $0.89 | $0.85 | $0.77 | $0.60 | $1.04 | $0.07 | $-0.06 | $-0.31 | $-0.46 | $-0.41 | $-0.39 | $-0.38 | $-0.38 | $-0.43 | $-0.34 | $-1.09 |
| Shares Outstanding (M) | 118M | 120M | 113M | 112M | 116M | 126M | 124M | 123M | 127M | 125M | 116M | 107M | 101M | 100M | 93M | 83M | 68M | 52M | 47M | 34M | 23M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $256M | $165M | $202M | $208M | $194M | $157M | $182M | $183M |
| Gross Profit | $252M | $162M | $200M | $203M | $191M | $155M | $179M | $180M |
| Gross Margin % | 98.4% | 98.2% | 98.7% | 97.8% | 98.2% | 98.5% | 98.4% | 98.4% |
| Operating Income (EBIT) | $41M | ($50M) | $4M | $10M | $27M | $3M | $25M | $47M |
| Operating Margin % | 16.1% | -30.1% | 2.2% | 4.9% | 13.7% | 2.2% | 13.9% | 25.5% |
| Net Income | $42M | ($31M) | $24M | $20M | $35M | $21M | $30M | $47M |
| Net Margin % | 16.4% | -18.9% | 12.0% | 9.5% | 18.1% | 13.1% | 16.7% | 25.6% |
| EBITDA | $41M | ($44M) | $10M | $16M | $32M | $10M | $32M | $53M |
| Earnings Per Share (EPS) | $0.36 | $-0.30 | $0.20 | $0.16 | $0.29 | $0.17 | $0.26 | $0.41 |
| Shares Outstanding (M) | 118M | 104M | 120M | 119M | 120M | 120M | 118M | 114M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $110M | $142M | $198M | $127M | $120M | $168M | $152M | $136M | $116M | $61M | $18M | $3M | ($27M) | ($37M) | ($36M) | ($27M) | ($22M) | ($18M) | ($18M) | ($11M) | ($23M) |
| Capital Expenditures (CapEx) | $3M | $0M | $2M | $0M | $0M | $0M | $1M | $1M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $1M |
| Free Cash Flow (FCF) | $107M | $142M | $196M | $127M | $120M | $167M | $151M | $135M | $115M | $61M | $18M | $3M | ($28M) | ($37M) | ($36M) | ($27M) | ($22M) | ($18M) | ($18M) | ($11M) | ($25M) |
| FCF Margin % | 12.9% | 18.6% | 29.0% | 26.3% | 29.8% | 45.8% | 42.6% | 44.1% | 45.9% | 38.0% | 22.4% | 6.2% | -103.8% | -359.0% | -1093.8% | — | — | -61982.8% | -8789.0% | -2274.7% | -8351.4% |
| Dividends Paid | — | — | — | — | $24M | $14M | $22M | $7M | — | $0M | $0M | $0M | $0M | $0M | $0M | $0M | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $34M | ($17M) | $38M | $54M | $44M | $5M | $59M | $74M |
| Capital Expenditures (CapEx) | $3M | $0M | $0M | $0M | $0M | $0M | $0M | $2M |
| Free Cash Flow (FCF) | $31M | ($17M) | $38M | $54M | $44M | $5M | $59M | $72M |
| FCF Margin % | 12.1% | -10.3% | 19.0% | 26.2% | 22.6% | 3.2% | 32.5% | 39.6% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $889M | $837M | $841M | $622M | $583M | $424M | $572M | $412M | $312M | $221M | $69M | $52M | $35M | $63M | $99M | $40M | $25M | $25M | $20M | $18M | $10M |
| Cash & Cash Equivalents | $111M | $120M | $128M | $136M | $66M | $78M | $477M | $31M | $207M | $104M | $52M | $40M | $24M | $55M | $93M | $40M | $25M | $24M | $15M | $11M | $9M |
| Total Liabilities | $183M | $189M | $161M | $115M | $82M | $48M | $48M | $41M | $36M | $30M | $27M | $33M | $38M | $42M | $37M | $5M | $4M | $2M | $3M | $3M | $4M |
| Total Debt (Short + Long-Term) | $2M | $1M | $1M | $0M | $1M | $1M | $2M | $2M | $0M | $0M | $15M | $28M | $34M | $35M | $32M | $0M | $0M | $0M | $0M | $0M | $0M |
| Total Shareholders' Equity | $706M | $648M | $680M | $507M | $502M | $376M | $523M | $371M | $276M | $191M | $41M | $18M | ($3M) | $21M | $62M | $35M | $21M | $22M | $17M | $15M | $6M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CORT viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms